Hapvida Participacoes e Investimentos (HAPV3)

Currency in BRL
12.51
-0.40(-3.07%)
Closed·
HAPV3 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
12.1513.05
52 wk Range
7.0044.85
Key Statistics
Bid/Ask
12.61 / 12.65
Prev. Close
13.05
Open
13.05
Day's Range
12.15-13.05
52 wk Range
7-44.85
Volume
10.95M
Average Vol. (3m)
11.85M
1-Year Change
-62.2624%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
HAPV3 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
15.23
Upside
+21.75%
Members' Sentiments
Bearish
Bullish
ProTips
High shareholder yield
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Sell
Moving Averages
Buy

Hapvida Participações e Investimentos S.A., together with its subsidiaries, operates in the healthcare sector in Brazil. It sells health insurance plans through its own clinical, outpatient, and hospital networks, as well as dental plans through an accredited network. Hapvida Participações e Investimentos S.A. was founded in 1979 and is headquartered in Fortaleza, Brazil.

Employees
66000
Market
Brazil

Hapvida Participacoes e Investimentos Earnings Call Summary for Q4/2025

  • Hapvida Q4 2025 EPS of $0.24 missed forecast of $0.56 by 57%; revenue of $7.92B fell short of $7.99B estimate, triggering 10.84% stock decline.
  • Company lost 140,000 net members due to elevated churn rates; Medical Loss Ratio reached 75.5% amid regulatory fines and increased litigation costs.
  • Adjusted EBITDA totaled BRL 714M while G&A expenses rose to 6.1% of revenue, pressured by regulatory penalties and operational inefficiencies.
  • CEO Jorge Pinheiro pledged to prioritize member retention strategies and operational optimization while maintaining strong liquidity for growth initiatives.
  • Stock trades near 52-week low at $7.32, down 78.5% over six months; management cautious on outlook amid competitive pressures and infrastructure expansion.
Last Updated: 03/19/2026, 09:47 AM
Read Full Transcript
Hapvida investor slides for Q4/2025
Hapvida Q4 2025 slides
Last Update: Mar 19, 2026
See full investor slides

Compare HAPV3 to Peers and Sector

Metrics to compare
HAPV3
Peers
Sector
Relationship
P/E Ratio
−43.6x1.5x−0.5x
PEG Ratio
−0.560.070.00
Price / Book
0.1x0.9x2.6x
Price / LTM Sales
0.2x0.5x3.2x
Upside (Analyst Target)
14.9%2.9%47.6%
Fair Value Upside
Unlock38.9%6.1%Unlock

Analyst Ratings

1 Buy
11 Hold
1 Sell
Ratings:
13 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 15.23
(+21.75% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Goldman Sachs
Hold11.00-12.07%18.00DowngradeMar 26, 2026
UBS
Hold21.00+67.87%-MaintainDec 23, 2025
Morgan Stanley
Buy25.00+99.84%-MaintainDec 23, 2025
UBS
Hold21.00+67.87%55.00DowngradeNov 18, 2025
Jefferies
Hold31.50+151.80%-New CoverageJul 30, 2025

Earnings

Latest Release
Mar 18, 2026
EPS / Forecast
0.36 / 0.56
Revenue / Forecast
7.91B / 7.99B
EPS Revisions
Last 90 days

HAPV3 Income Statement

People Also Watch

21.19
BRAV3
+0.38%
30.62
UGPA3
+1.82%
22.75
AZZA3
+2.57%
56.40
CPFE3
+0.80%
13.44
RECV3
-1.17%

FAQ

What Is the Hapvida (HAPV3) Stock Price Today?

The Hapvida stock price today is 12.51 BRL.

What Stock Exchange Does Hapvida Trade On?

Hapvida is listed and trades on the B3 Stock Exchange.

What Is the Stock Symbol for Hapvida?

The stock symbol for Hapvida is "HAPV3."

What Is the Hapvida Market Cap?

As of today, Hapvida market cap is 5.94B BRL.

What Is Hapvida's Earnings Per Share (TTM)?

The Hapvida EPS (TTM) is -0.28.

When Is the Next Hapvida Earnings Date?

Hapvida will release its next earnings report on May 07, 2026.

From a Technical Analysis Perspective, Is HAPV3 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Hapvida Stock Split?

Hapvida has split 2 times.

How Many Employees Does Hapvida Have?

Hapvida has 66000 employees.

What is the current trading status of Hapvida (HAPV3)?

As of Apr 15, 2026, Hapvida (HAPV3) is trading at a price of 12.51 BRL, with a previous close of 13.05 BRL. The stock has fluctuated within a day range of 12.15 BRL to 13.05 BRL, while its 52-week range spans from 7.00 BRL to 44.85 BRL.

What Is Hapvida (HAPV3) Price Target According to Analysts?

The average 12-month price target for Hapvida is 15.23 BRL, with a high estimate of 31.5 BRL and a low estimate of 7 BRL. 1 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Neutral. The stock has an +21.75% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.